Venkatesan Jay
SEC Form 4 insider trading activity
Venkatesan Jay has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Venkatesan Jay is listed as Director at Serina Therapeutics, Inc. Inside the rolling window, Venkatesan Jay reported 1 open-market purchase totaling $1K in SER and no open-market sales.
Companies traded
Other insiders at SER
Insider Buying
$1K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Venkatesan Jay made?
Venkatesan Jay has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Venkatesan Jay trade?
Venkatesan Jay has filed SEC Form 4 disclosures for 1 company, including SER.
When was Venkatesan Jay's most recent SEC Form 4 filing?
Venkatesan Jay's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Venkatesan Jay's total buy and sell value in the current window?
Inside the rolling retention window, Venkatesan Jay bought $1K and sold $0 based on SEC Form 4 filings.
What was Venkatesan Jay's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 589 SER shares on 2026-05-22, worth $1K, per SEC Form 4 filings.